mwb research downgrades Stratec stock from Hold to Sell

Published on 10/06/2026 at 15:25 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Second-quarter revenue rose 2.40 percent and adjusted EBIT margin reached 11.90 percent. Stratec stock costs EUR 22.08 on October 6, 2026 after EUR 20.85.

Techniker montieren automatisiertes Diagnostik-Analysegerät in modernem Reinraum — Stratec SE (DE000STRA555) fertigt automatisierte Analysesysteme, hier ein Reinraum mit Laborrobotik im Einsatz, Illustration mit AI erstellt.

Stratec (ISIN DE000STRA555) was downgraded from Hold to Sell by mwb research on September 17, 2026, according to FinanzNachrichten. The research firm kept its price target at EUR 21.00, putting the rating change against a stock price that was already above that target.

Second-quarter recovery remains measured

According to FinanzNachrichten, Stratec's second-quarter 2026 revenue rose 2.40 percent on a currency-adjusted basis from the prior year, while adjusted EBIT margin recovered to 11.90 percent. The comparison matters because the first quarter had been substantially weaker, making the second-quarter margin a clearer test of underlying profitability.

Stratec develops automated instruments and solutions for in-vitro diagnostics and life science customers. Its investor-relations materials describe laboratory automation as the company's core market and identify instrumentation, Diatron and smart consumables as operating areas, according to STRATEC.

Second-half revenue sets the hurdle

The downgrade rests on execution rather than on the second-quarter figures alone. FinanzNachrichten reported that the full-year 2026 plan would require second-half revenue of EUR 149.00 million to EUR 161.00 million, equivalent to growth of 12.00 percent to 22.00 percent versus the second half of 2025.

That range leaves demand and recurring revenue as the key variables for the rest of fiscal 2026. The same analysis cited volatile customer ordering behavior and weak recurring revenue, while noting that the expected normalization had become largely reflected in the share price.

Stock trades above the target

Stratec's market capitalization stood at EUR 261.4 million on October 6, 2026. At Lang & Schwarz, the stock was trading at EUR 22.08 on October 6, 2026 at 3:15 p.m. CEST, up 5.90 percent versus the prior close of EUR 20.85 on October 5, 2026.

The further course of trading is shown by the continuously updated real-time quote of Stratec stock.